HDAC9 and systemic lupus erythematosus: In our current studies, we treated NZB/W mice for only 4 weeks after disease onset and sought to determine mechanisms by which this cytoplasmic HDAC inhibitor might alter the cellular functions involved in lupus pathogenesis and especially the maintenance of GC and PC generation.